Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?
- PMID: 28536496
- PMCID: PMC5422419
- DOI: 10.21147/j.issn.1000-9604.2017.02.10
Link between dysregulated hypoxia signaling and aberrant methylation in clear cell renal cell carcinoma?
Conflict of interest statement
Conflicts of Interest: The authors have no conflicts of interest to declare.
Similar articles
-
The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma.J Urol. 2010 Feb;183(2):743-51. doi: 10.1016/j.juro.2009.09.086. J Urol. 2010. PMID: 20022054
-
LAT, HOXD3 and NFE2L3 identified as novel DNA methylation-driven genes and prognostic markers in human clear cell renal cell carcinoma by integrative bioinformatics approaches.J Cancer. 2019 Oct 22;10(26):6726-6737. doi: 10.7150/jca.35641. eCollection 2019. J Cancer. 2019. PMID: 31777602 Free PMC article.
-
Immunohistochemical expression of hypoxia inducible factor-1alpha and its downstream molecules in sarcomatoid renal cell carcinoma.J Urol. 2007 Apr;177(4):1258-63. doi: 10.1016/j.juro.2006.11.100. J Urol. 2007. PMID: 17382701
-
Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.Int J Mol Sci. 2017 Aug 16;18(8):1774. doi: 10.3390/ijms18081774. Int J Mol Sci. 2017. PMID: 28812986 Free PMC article. Review.
-
[Aberrant methylation of tumor suppressor genes in renal cell carcinoma].Ai Zheng. 2007 Nov;26(11):1276-80. Ai Zheng. 2007. PMID: 17991333 Review. Chinese.
References
-
- Shenoy N, Vallumsetla N, Zou Y, , et al. Role of DNA methylation in renal cell carcinoma. J Hematol Oncol. 2015;8:88. doi: 10.1186/s13045-015-0180-y. [Shenoy N, Vallumsetla N, Zou Y, et al. Role of DNA methylation in renal cell carcinoma. J Hematol Oncol 2015;8:88. <DOI: 10.1186/s13045-015-0180-y> <PMID: 26198328>] - DOI - PMC - PubMed
-
- Shenoy N, Pagliaro L. Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective. Ann Oncol. 2016;27:1685–95. doi: 10.1093/annonc/mdw241. [Shenoy N, Pagliaro L. Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective. Ann Oncol 2016;27:1685-95. <DOI: 10.1093/annonc/mdw241> <PMID: 27329246>] - DOI - PubMed
-
- Cancer Genome Atlas Research Network. Compre-hensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013;499:43–9. doi: 10.1038/nature12222. [Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499:43-9. <DOI: 10.1038/nature12222> <PMID: 23792563>] - DOI - PMC - PubMed
-
- Li M, Wang Y, Song Y, , et al. Aberrant DNA methyl-transferase 1 expression in clear cell renal cell carcinoma development and progression. Chin J Cancer Res. 2014;26:371–81. doi: 10.3978/j.issn.1000-9604.2014.08.03. [Li M, Wang Y, Song Y, et al. Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression. Chin J Cancer Res 2014;26:371-81. <DOI: 10.3978/j.issn.1000-9604.2014.08.03> <PMID: 25232208>] - DOI - PMC - PubMed
-
- Hu CY, Mohtat D, Yu Y, , et al. Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival. Clin Cancer Res. 2014;20:4349–60. doi: 10.1158/1078-0432.CCR-14-0494. [Hu CY, Mohtat D, Yu Y, et al. Kidney cancer is characterized by aberrant methylation of tissue-specific enhancers that are prognostic for overall survival. Clin Cancer Res 2014;20:4349-60. <DOI: 10.1158/1078-0432.CCR-14-0494> <PMID: 24916699>] - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources